ACARIX AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3765 SEK | +8.35% |
|
+12.43% | +97.84% |
| 06-11 | Acarix Announces Enrollment of First Patient in Us-Based Clinical Workflow Evaluation Study | CI |
| 05-27 | Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACARIX AB | Medical Diagnostic & Testing Equipment | +8.35% | +12.43% | +97.84% | -35.37% | -91.56% | 32.15M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- ACARIX Stock
- Charts Acarix AB
- Comparison Chart
